Farther Finance Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.87K Buy
802
+20
+3% +$131 ﹤0.01% 4831
2026
Q2
$4.48K Buy
782
+27
+4% +$117 ﹤0.01% 4854
2026
Q1
$2.97K Buy
755
+1
+0.1% +$4 ﹤0.01% 4746
2025
Q4
$3.15K Buy
754
+714
+1,785% +$2.76K ﹤0.01% 4512
2025
Q3
$132 Buy
+40
New +$113 ﹤0.01% 4797
2024
Q3
– Sell
-78
Closed -$121 – 4092
2024
Q2
$121 Hold
78
– – ﹤0.01% 3577
2024
Q1
$112 Hold
78
– – ﹤0.01% 3362
2023
Q4
$105 Buy
+78
New +$92 ﹤0.01% 3297

Other funds holding PGEN

Farther Finance Advisors's PGEN Position: Q3 2026 in Review

Farther Finance Advisors increased its Precigen (PGEN) stake by 2.6% in Q3 2026, buying an estimated $131 and bringing the position to 802 shares worth $6.87K. The position accounts for ﹤0.01% of the portfolio, ranked #4831.

Farther Finance Advisors first reported a position in PGEN in Q4 2023 and has held it in 8 quarters since. 8 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.

  • Farther Finance Advisors held 802 shares of Precigen worth $6.87K as of Q3 2026.
  • Farther Finance Advisors bought 20 Precigen shares in Q3 2026, an estimated $131.
  • Precigen made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4831 holding.
  • Farther Finance Advisors first reported a position in Precigen in Q4 2023 and has held it in 8 quarters since.
  • 8 funds tracked by Wall St. Rank held Precigen as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.